Skip to content
Search

Latest Stories

GPhC stops routine inspections in response to COVID-19

General Pharmaceutical Council (GPhC) today announced that it will be stopping routine inspections of pharmacies and producing inspection reports in light of the COVID-19 crisis.

The regulator said it will work differently and move on to a supportive role in carrying out its functions.


“If one of our inspectors contacts you on the phone or visits your pharmacy, it will be to discuss your plans and arrangements for the pandemic,” Duncan Rudkin, chief executive, said in a letter to pharmacy professionals and owners.

“Our inspectors will be answering queries and providing support to pharmacy owners, pharmacy professionals and teams.”

Rudkin said the GPhC will share best practices identified by its inspectors through its online knowledge hub and to other organisations.

He added that flexible regulatory standards will help pharmacists when they have to prioritise patient needs over rules.

“We recognise that in highly challenging circumstances, pharmacy professionals and teams may need to depart from established procedures in order to care for patients and people using health and social care services. Our regulatory standards are designed to be flexible and to provide a framework for decision-making in a wide range of situations,” he said.

Earlier in the day, the Royal Pharmaceutical Society has called for a change in law to minimise potential medicine shortages, by allowing community pharmacists “to use their professional judgement to help manage the supply of medicines without the bureaucracy that currently exists.”

Rudkin informed that the agency is preparing for issuing temporary registrations for pharmacists and pharmacy technicians, in case an emergency is declared, and will be contacting those who may be added to the temporary register later this week.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less